A 2020 review by Davidson and Zhang summarized studies using a mAb targeting a key pathogenic epitope from insulin to treat a spontaneous mouse model of T1D and discussed the translational potential of therapies based on this approach [81]. The gene discussed is INS; the disease is type 1 diabetes mellitus.